Fluvastatin and Retrognathia - a phase IV clinical study of FDA data

Summary:

Retrognathia is reported as a side effect among people who take Fluvastatin (fluvastatin), especially for people who are female, 0-1 old, also take Colecalciferol, and have Foetal exposure during pregnancy.

The phase IV clinical study analyzes which people have Retrognathia when taking Fluvastatin. It is created by eHealthMe based on reports of 3,958 people who have side effects when taking Fluvastatin from the FDA, and is updated regularly.

What is Fluvastatin?

Fluvastatin has active ingredients of fluvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 3,999 Fluvastatin users. Check the latest studies of Fluvastatin.

What is Retrognathia?

Retrognathia (a condition in which either or both jaws recede with respect to the frontal plane of the forehead) is found to be associated with 38 drugs and 100 conditions by eHealthMe. Check the latest studies of Retrognathia.

On Jul, 16, 2026

3,958 people reported to have side effects when taking Fluvastatin.
Among them, 19 people (0.48%) have Retrognathia.

Among these 19 people:

What is the gender of people who have Retrognathia when taking Fluvastatin? *

female: 100 %
male: 0.0 %

What is the age of people who have Retrognathia when taking Fluvastatin? *

What are other drugs people take besides Fluvastatin? *

What are other side effects people have besides Retrognathia? *

Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 19 people, 100.00%
Limb Reduction Defect (a birth defect in which all or some of the limbs of a foetus do not completely form while in utero): 17 people, 89.47%
Neck Deformity (neck malformation): 16 people, 84.21%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 16 people, 84.21%
Aplasia (defective development or congenital absence of an organ or tissue): 15 people, 78.95%
Limb Hypoplasia Congenital (incomplete developed limb): 14 people, 73.68%
Premature Baby: 11 people, 57.89%
Premature Rupture Of Membranes: 3 people, 15.79%
Premature Delivery: 2 people, 10.53%
Low Birth Weight Baby: 1 person, 5.26%

What are the existing conditions these people have? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 9 people, 47.37%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 5 people, 26.32%
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli): 5 people, 26.32%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 21.05%
High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Fluvastatin and have Retrognathia?

- Check whether Retrognathia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fluvastatin:

Fluvastatin (3,999 reports)

Retrognathia treatments and more:

Retrognathia (404 reports)

Browse all side effects of Fluvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retrognathia:

Retrognathia (38 drugs)

Browse all the conditions that are associated with Retrognathia:

Retrognathia (100 conditions)

Related publications that referenced our studies

Liao KF, Huang PT, Lin CC, Lin CL, Lai SW, "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2017 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Liao KF, Huang PT, Lin CC, Lin CL, Lai SW, "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2017 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluvastatin (the active ingredients of Fluvastatin) and Fluvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.